Sign in to view content

Apples and Oranges: "Real-World" Outcomes Differ From Clinical Trial Outcomes Because "Real-World" Patients Differ From Clinical Trial Patients

Franco M. Recchia, MD

Video
Published 2021

Related

Treatment course and outcomes of neovascular age-related macular degeneration in patients receiving intraocular pressure-lowering drops
Bobeck S Modjtahedi, MD
On Demand Cases, Courses, and Papers
2019
Silicone Oil Large and Small Droplets 8 Days Post Avastin (Avella) Injection
Paul E. Tornambe, MD
Lon S. Poliner, MD
Retina Image Bank: Images of the Week
2016
Assessing Supplemental Injection Use Across Groups in the Phase 2 DAVIO 2 Trial of EYP-1901 vs Aflibercept in Wet Age-Related Macular Degeneration
Veeral S. Sheth, MD, MBA, FASRS, FACS
Annual Meeting Talks
2024

Category: AMD-Neovascular

See more